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This study evaluated the therapeutic action of hydroethanolic extract of Trianthema portulacastrum L. (TPE) on  
N-nitroso-N-methylurea (NMU)-induced mammary tumors in Wistar rats. A hydroethanolic was prepared and subjected to 
qualitative and quantitative phytochemical screening. After acclimatization, Wistar rats were divided into 4 groups of 6 rats 
each: Group A (vehicle control), Group B (TPE control), Group C (TPE treatment) and group D (NMU control). NMU  
(50 mg/kg body weight) was injected intraperitoneally at 50, 80 and 110 days of age. After the induction of palpable tumors, 
the rats were administered 200 mg/kg bw of TPE by oral gavage for 2 months. The treatment with TPE significantly 
(p<0.05) decreased tumor incidence, frequency, size and malignancy in comparison to the tumor-bearing rats that were not 
administered TPE. Immunohistochemical analysis revealed that TPE treatment significantly reduced the expression of 
PCNA, VEGF, ER-α and ER-β, and caused non-significant reductions in matrix metallopeptidase-9 (MMP-9). Caspase-3 
expression significantly increased in TPE-treated rats in comparison with NMU-treated controls. The qRT-PCR results 
showed PCNA and ER-β expression was down regulated and caspase-3 expression was up regulated in the TPE-treated 
group. The present study showed the in vivo therapeutic action of TPE extract on NMU-induced mammary tumors. TPE 
exhibited antitumor activity through its antiproliferative, antiangiogenic, pro-apoptotic, and estrogen receptor-modulatory 
properties. 
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Cancer is one of the most complex and aggressive 
diseases in both humans and animals. A total of 
1,806,590 new cases of tumors will be detected, and 
606,520 cancer death were projected to arise in the 
United States of America in 20201. Breast cancer 
constitutes a major problem worldwide; it comprises 
one-tenth of all new cancer diagnoses and is a most 
important cause of mortality in women2. The causes 
for the initiation of mammary tumour are sex, obesity, 
sedentary lifestyle, alcohol, diet, hormone transition 
during menopause, ionizing radiation and aging3. The 
current treatments available for early-stage breast 
cancer, such as chemotherapy, radiation therapy, 
surgery, immunotherapy, hormone therapy, vaccines 
and targeted therapy, are costly, have many side 
effects and kill normal cells in addition to cancer 
cells4. Recently, several studies have shown that 
naturally occurring chemotherapeutic substances are 
capable of the inhibition and reversal of different 
stages of carcinogenesis5,6. Therefore, it is of interest 
to explore the possibility of using plant-based 
phytochemicals or other dietary chemicals, such as 
chemotherapeutic agents6,7. 
 
The weed T. portulacastrum L. (family Aizoaceae), 
which is widely present in tropical countries including 
India. The plant is a versatile component of  
the indigenous Ayurveda and Unani medicines8.  
The principal constituents of T. portulacastrum  
are trianthenol, ecdysterone, 3-acetylaleuritolic  
acid, leptorumol, 5,2-dihydroxy-7-methoxy-6,8-
dimethylflavone, 3,4-dimethoxycinnamic acid,  
p-methoxybenzoic acid, 5-hydroxy-2-methoxy-
benzaldehyde and betacyanin9,10. T. portulacastrum, 
known traditionally as Biskhapra, has been widely used 
for the treatment of urinary system disorders, ascites, 
blood pressure, anemia, inflammation, night blindness 
————— 
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and as an analgesic, stomachic and laxative8-10. 
Experimentally, TPE have been proven to exert 
nephroprotective, hepatoprotective11, antioxidative12, 
anti-inflammatory and hypolipidemic activities13. 
Recently, Bishayee and Mandal14 reported that ethanolic 
TPE showed chemopreventive activity against 7,12-
dimethylbenz[a]anthracene (DMBA)-induced mammary 
tumors in rats. Mandal and Bishayee also reported that 
T. portulacastrum prevented DMBA-induced mammary 
neoplasia by anti-inflammatory mechanism controlled 
by NF-κB and Nrf2 signaling pathways15. 
DMBA and NMU-induced mammary tumors in rats 
are widely accepted as a model for the study of cancer 
pathogenesis and the development of chemotherapeutic 
and chemoprevention agents for breast cancer7,14,16-18. 
The dynamic process of tumor development can be 
evaluated through the expression of tumor markers, 
such as PCNA, caspase-3, VEGF, estrogen receptors 
and MMP-9, in cancer cells in comparison with their 
expression in normal cells; this has been effectively 
used in the diagnosis and prognosis of tumors18. 
Investigations on tumor cell proliferation, invasiveness, 
angiogenesis and apoptosis can help detect the tumor 
stage as well as the therapeutic response7,14,19. The 
present study aimed to assess the therapeutic action of 
TPE on the expression of cancer molecular markers in 
NMU-induced mammary tumors in Wistar rats. A total 
of 6 biomarkers (PCNA, VEGF, caspase-3, ER-α, ER-
β, and MMP-9), which are responsible for the 
multistage progression of cancer, were studied in tumor 
tissues, and the mRNA expression of the PCNA, 
caspase-3 and ER-β genes was evaluated to understand 
mechanism of tumor regression. 
 
Methodology 
 
Plant materials 
T. portulacastrum was collected from the ICAR-
IVRI campus, Izatnagar, Barielly district, Uttar 
Pradesh, India. The plant was authenticated by the 
CSIR-National Botanical Research Institute (NBRI), 
Lucknow, India and a voucher specimen (LWJ-029) 
was submitted in its herbarium. 
 
Hydroethanolic extraction 
The entire plant (excluding the roots) was air-dried 
in the shade and ground. The ground plant powder 
was extracted in hydroethanolic solvent (distilled 
water and ethanol; 1:1) in the ratio of 1:6 (plant 
powder: solvent) by using Soxhlet apparatus for 8 h at 
80°C. The extract was passed through Whatman No. 1 
filter paper and evaporated in a water bath until it 
dried to thick, sticky paste. For further use, the sticky 
paste was suspended in normal saline to a final 
concentration of 50 mg/mL. 
 
Qualitative phytochemical analysis 
The qualitative phytochemical analysis of 
hydroethanolic extract of T. portulacastrum was 
conducted to detect the alkaloids, steroids, terpenoids, 
flavonoids, glycosides, saponins, carbohydrates and 
phenolic compounds, by using the procedures 
described by Kokate20, Harborne21 and Thimmaiah22. 
 
Quantitative analysis of phytochemical constituents 
 
Total phenolic content estimation 
The total phenolic content of the hydroethanolic 
extract of T. portulacastrum was measured by using 
the Folin–Ciocalteu (FC) reagent23. Linearity was 
noticed in the range of 0.25–1 mg/mL. The total 
phenolic content in the hydroethanolic extract was 
calculated through comparison with the standard 
curve and expressed as mg gallic acid equivalent 
(GAE) per g of extract. 
 
Estimation of total flavonoid content (Aluminum chloride 
colorimetric method) 
The aluminum chloride colorimetric method was 
modified from the procedure reported by Woisky and 
Salatino24. Catechin was used to construct the 
calibration curve. The total flavonoid content was 
calculated as mg catechin equivalent (CE) per g of 
extract. 
 
Chemicals and antibodies 
NMU, 3-Aminopropyl) triethoxysilane (APES) and 
Extr Avidin peroxidase was obtained from Sigma-
Aldrich (St. Louis, MO, USA). Primary antibodies 
PCNA (PC10, sc-56), VEGF (C-1, sc-7269), caspase-
3 (H-277, sc-7148), ER-α (H-184, sc-7207), ER-β (H-
150, sc-8974) and MMP-9 (c-20, sc-6840), secondary 
antibodies [goat anti-mouse IgG-B (sc-2039) and goat 
anti-rabbit IgG-B (sc-2040)] and normal goat serum 
(sc-2043) were procured from Santa Cruz 
Biotechnology Inc., Santa Cruz, CA, USA. Various 
chemicals like TRIzol reagent (Invitrogen Life 
Technologies, Carlsbad, CA, USA), DNase I (MBI 
Fermentas, USA), RNAlaterTM (Qiagen, Hilden, 
Germany), 3,3’-Diaminobenzidine (DAB, Vector 
Laboratories Inc., Burlingame, CA, USA), Revert Aid 
First Strand cDNA synthesis kit (Thermo Scientific, 
USA), and real time One Step Prime Script™ RT-
PCR kit (Takara Bio Inc, Japan) were procured from 
standard company. 
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Experimental animals 
Female Wistar rats, approximately 30 days old, 
were provided by Laboratory Animals Resource 
(LAR) Section of ICAR-IVRI, Izatnagar, and 
maintained in the experimental animal shed, Division 
of Pathology. The rats were housed in polypropylene 
cages under suitable environmental conditions (30–
55% relative humidity; 27±2°C temperature) in a 12-h 
light/dark cycle. The rats were acclimatized for 1 
week and provided standard diet and water ad libitum. 
The experimental design was approved by the 
Institute Animal Ethics Committee (IAEC), vide letter 
no F.1-53/2012-13/JD(R), dated 16/08/2014. 
 
Experimental design 
After acclimatization, the rats were divided into 4 
groups. In group A (n=6), the rats received an 
intraperitoneal injection of acidified saline only and 
served as the vehicle control. In group B (n=6), the 
rats received 200 mg/kg bw TPE entire experiment 
and acted as TPE control. In group C (n=6), the rats 
were administered with 200 mg/kg bw TPE for 2 
months after the appearance of palpable tumors. In 
group D (n=6), the rats with tumors received only 
normal saline and served as the NMU control. 
 
Chemical induction of mammary tumors 
Immediately prior to its use, NMU was dissolved 
in 0.9% acidified saline (pH 4.0) to a final 
concentration of 5 mg/mL and was intraperitoneally 
administered at a concentration of 5 mg/100 g bw. 
The injection was administered in ventral midline, 
half way between the two sites of 3rd and 4th pair of 
mammary glands18. 
 
Clinical observation 
The rats were palpated daily to detect any tumor 
growth, and their bw were measured at weekly 
intervals. The size (diameter) and gross appearance of 
developed tumors were recorded on alternate days. 
Tumor frequency was calculated from the average 
number of tumors per tumor-bearing rat. Inhibition of 
tumor multiplicity=(Total no. of tumors in the 
carcinogen control)–(total no. of tumors in TPE 
treated)×100/Total no. of tumors in the carcinogen 
control. 
 
Histopathological studies 
The rats were killed and subjected to necropsy at 
the end of the experiment. At necropsy, the tumors 
were observed for position, size, color and 
consistency. The tissues from normal mammary 
glands and the mammary tumors were collected in 
10% neutral buffered formalin for the preparation of 
5-μm-thick paraffin-embedded sections and stained 
with hematoxylin and eosin (H&E). The stained 
tumor sections were classified and graded in 
accordance with the method of Russo and Russo16. 
Carcinomas and normal mammary gland samples 
were also collected in RNAlaterTM (RNA Stabilization 
Reagent) for mRNA extraction and stored at -80ᵒC. 
 
Immunohistochemical staining 
The duplicate paraffin sections collected on clean 
APES-coated glass slides were dew axed and 
rehydrated through a graded ethanol series and distilled 
water. Antigen retrieval was achieved by microwaving 
the samples in 10 mM tri-sodium citrate buffer for 15 
min and then washed with PBS. Endogenous 
peroxidase was blocked by incubation with 3% H2O2, 
and then samples were incubated with 5% serum for 
block non-specific antigen binding. The sections were 
incubated overnight in humidified chamber at 4°C with 
primary antibodies targeted against PCNA, VEGF, 
caspase-3, ER-α, ER-β, and MMP-9 (Table 1), 
incubated with biotinylated secondary antibody for 30 
min at RT, and then incubated with ExtrAvidin 
peroxidase for 30 min at RT. DAB was used to detect 
the Ag-Ab complex. When acceptable color intensity 
was obtained, the slides were washed and counter-
stained with Mayer’s hematoxylin. The slides were 
rehydrated using an ascending gradient series of 
alcohol and mounted in DPX mountant. 
 
Semi-quantitative analysis of immunoreactive cells 
PCNA immunostaining was evaluated through 
counting positive and negative nuclei from a 
minimum of 1000 neoplastic cells in 8–10 
Table 1 — Antibodies used for immunohistochemistry in this experiment 
Antibodies Clone/Origin Blocking serum (5%) Primary antibody dilution Secondary antibody dilution 
PCNA Mouse monoclonalantibody Normal goat 1:500 1:100 
VEGF Mouse monoclonalantibody Normal goat 1:200 1:100 
Caspase-3 Rabbit polyclonal antibody Normal goat 1:200 1:100 
ER-α Rabbit polyclonalantibody Normal goat 1:200 1:100 
ER-β Rabbit polyclonalantibody Normal goat 1:200 1:100 
MMP-9 Goat polyclonalantibody Normal donkey 1:150 1:100 
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representative high-power fields. Other markers were 
analyzed by using the method proposed by Franchi et 
al. 0, no stained cells; 1, ≤25% stained cells; 2, >25% 
and ≤50% stained cells; 3, >50% and ≤75% stained 
cells; and 4, >75% stained cells25. 
 
RNA extraction and reverse transcription 
Total RNA was extracted from mammary tumors 
and normal mammary glands by using TRIzol® 
reagent and phenol-chloroform extraction. Reverse 
transcription was performed with RevertAid First 
Strand cDNA synthesis kit by using random primers. 
An aliquot of 500 ng RNA was used to synthesize 
cDNA, and 1 μL reverse transcriptase was used for 
the subsequent experiments. 
 
Quantitative single step real-time polymerase chain reaction 
(qRT-PCR) 
Real-time PCR was conducted in an Applied 
Biosystems 7500 thermocycler using SYBR Green I. 
Each PCR mixture contained 10 μL 2×One-step 
SYBR® RT-PCR Buffer 4, 100 ng total RNA, and 10 
μM of each primer (Table 2). Gene expression was 
measured through quantification of the mRNA with 
respect to a calibrator sample (mRNA from a normal 
mammary gland). All quantifications were normalized 
with endogenous control GAPDH. The relative value 
obtained for quantification was expressed as 2-ΔΔCt, 
where ΔCt represents difference between the Ct value 
of sample and that of GAPDH in the same sample, 
and 2-ΔΔCt is difference between the ΔCt value of a 
sample and that of the calibrator sample (normal 
mammary gland). 
 
Statistical analysis 
SPSS software (version 17) was used for the 
statistical analyses. All data are expressed as mean±SE. 
ANOVA was used to detect difference between various 
groups. Post hoc analysis was performed by using 
Tukey’s test. Probability (p) values of less than 0.05 
indicated statistical significance. 
 
Results 
 
Phytochemical analysis 
The preliminary phytochemical screening of the 
hydroethanolic extract of T. portulacastrum revealed 
the presence of steroids, alkaloids, terpenoids, 
glycosides, flavonoids, phenolic compounds, 
saponins, anthraquinones and carbohydrates. The total 
phenolic content in the extract was found to be 93±3.9 
mg/g GAE. The total flavonoid content in the extracts 
was found to be 65±2.1 mg/g CE. 
 
General observations 
There was no evidence of acute toxicity after the 
administration of NMU or TPE. No differences in 
food consumption, water intake, and behavioral 
changes were observed among groups throughout the 
experimental period (24 weeks). However, the NMU 
control rats were more depressed, weaker, had lower 
body weight, and experienced hair loss. 
TPE Reduces size and number of NMU-induced mammary 
tumors 
Most of the tumors in the NMU-treated rats were 
large, solid in consistency (Fig. 1a), and locally 
invasive, with multiple growths that subsequently 
coalesced to become a large tumor mass overlain by 
necroses and ulcers. The tumors had a more 
prominent blood supply in the NMU control (Fig. 1a), 
whereas the TPE-treated group had no prominent 
blood supply (Fig. 1b). The treatment of rats with 
TPE also reduced the number and size of tumor  
(Fig. 1c & Fig. 1d). The size of the tumors was 5–6.5 cm 
Table 2 —  List of primers used for RT-PCR and qRT-PCR 
Target gene Primer sequence (5′-3′) Annealing temperature Product size (bp) Reference 
GAPDH F: GTTACCAGGGCTGCCTTCTC 
R: GGGTTTCCCGTTGATGACC  
56°C 168 [26] 
PCNA F: GAGTGGGGAGCTTGGCAAT 
R: ACAACAAGGGGTACATCTGC 
55°C 198 This study 
VEGF F: CAGCTATTGCCGTCCAATTGA 
R: CCAGGGCTTCATCATTGCA 
56°C 131 [27] 
Caspase-3 F: GCTGGACTGCGGTATTGAGA 
R: CGTACAGTTTCAGCATGGCG 
55°C 179 This study 
Estrogen-α F: TAAGAACCGGAGGAAGAGTTG 
R: TCATGCGGAATCGACTTG 
45°C 623 [28] 
Estrogen-β F: AAGTAGCCGGAAGCTGACAC 
R: CCGGGACCACATTTTTGCAC 
57°C 197 This study 
MMP-9 F: CCACCGAGCTATCCACTCAT 
R: GTCCGGTTTCAGCATGTTTT 
59°C 159 [29] 
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in diameter in the NMU control group (Fig. 1e) and 3–4 
cm in the TPE treatment group (Fig. 1d) and led to 
multifocal necrotic areas (Fig. 1f). The tumor frequency 
was 3.5 times higher in the NMU control, whereas it 
reduced to 1.5 times in TPE treatment group. The 
inhibition of tumor multiplicity was 57.14%, which 
indicated that TPE reduced tumor multiplicity in NMU-
induced mammary carcinogenesis. 
 
TPE Induces intratumoral necrosis 
In the NMU control group that comprised 6 rats, a 
total of 21 tumors developed: 20 were malignant (17 
invasive carcinoma and 3 non-invasive in situ 
carcinoma) and 1 was benign. In the TPE-treatment 
group, 9 tumors were observed in 6 rats; 2 were benign 
and 7 were malignant (3 invasive carcinoma and 4 non-
invasive in situ carcinoma). Histopathologically, the 
tumors in the NMU-control group showed epithelial 
proliferation both in the lumen of the mammary duct and 
the alveoli, which resulted in a fused glandular pattern 
(Fig. 1g). The tumors also showed various 
combinations, such as papillary and cribriform 
carcinomas of both in situ and invasive types. The tumor 
sections exhibited fewer areas of necrosis, prominent 
blood vessels and multi-layered epithelium around the 
alveoli. The neoplastic cells showed pleomorphism, 
nuclear enlargement and many mitotic structures (Fig. 
1g). In the TPE-treatment group, the alveoli were 
lined by a multilayered epithelium surrounded by 
extensive areas of necrotic debris, fewer mitotic 
structures and fewer blood vessels (Fig. 1h). Vehicle 
control and TPE control groups showed normal 
histopathological changes in the mammary gland 
characterized by fully differentiated alveoli lined by a 
single layer of low cuboidal epithelium (Fig. 2a & 
Fig. 2b). 
 
Antiproliferative effect of TPE 
The expression patterns revealed by 
immunohistochemical (IHC) analysis revealed was 
used to assess the effect of TPE on cellular 
proliferation in NMU-induced mammary tumor. The 
level of PCNA expression in all groups showed 
significant variation. Tumor sections from the NMU-
control rats had more than 75% PCNA-positive cells, 
which indicated an increase in cell proliferation  
(Fig. 3a). A significant (p<0.05) reduction in PCNA 
expression in the TPE-treated group was indicative of 
the antiproliferative effect of TPE (Fig. 3b & Fig. 
4A). The mRNA expression of PCNA in normal 
mammary gland, NMU control and TPE-treated 
tumors was measured by qRT-PCR. In the TPE-
treated group, PCNA expression was down regulated 
in comparison with the NMU control, but up 
regulated in the NMU control in comparison with 
normal mammary glands (Fig. 4B). 
 
 
 
Fig. 2 TPE-mediated gross and histopathological changes in NMU-
induced mammary tumors in rats. a) Mammary tumors are multiple,
large, and grayish lobulated mass. The L1 mammary tumor is
connected to a coalesced mass of mammary tumors (L4, L5, and L6) 
by two prominent blood vessels (arrow). b) TPE treatment caused a
reduction in mammary tumor size, number, and blood supply (arrow).
c) Dissected tumor mass measuring 5.5 cm in diameter in the NMU
control. d) Dissected tumor mass in the TPE-treated group measuring 
2.8 cm in diameter. e) Dissected tumor mass from the NMU control
showing multi-lobuled solid mass without necrosis (arrow). f) A cut
section of the tumor mass from the TPE-treated group showing 
extensive areas of necrosis (arrow). g) Invasive papillary carcinoma: 
Pleomorphic cancer cells are arranged in solid sheets with marked
desmoplasia and mitotic figures (arrow). H&E ×200. h) Invasive
papillary carcinoma with comedo pattern: Inward papillary growths
within lumen filled with necrotic eosinophilic mass (arrow).
H & E ×200. 
 
 
Fig. 1 — Histopathological changes in the mammary gland of Vehicle
control (a) and TPE control (b) groups. Normal mammary gland
revealed fully differentiated alveoli lined by single layer of low
cuboidal epithelium. H & E ×100. 
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TPE Inhibits intratumor angiogenesis 
To assess whether TPE inhibited angiogenesis in 
NMU-induced mammary tumors, the expression of 
VEGF was assessed in tumor sections by IHC 
analysis. Elevation in the expression of VEGF was 
noticed in NMU control rats, which was indicative of 
an increase in angiogenic activity (Fig. 3c). However, 
significantly (p<0.05) decreased VEGF expression in 
TPE-treated group indicated antiangiogenic activity of 
TPE (Fig. 3d). 
 
TPE Induces apoptosis in mammary tumors 
To determine the extent of apoptosis in NMU-
induced tumors, we assessed caspase-3 expression by 
IHC analysis and qRT-PCR. The amount of caspase-3 
immunopositive cells was much lower in the NMU 
control (Fig. 3e) in comparison with the TPE-treated 
group; the frequency of immunopositive staining was 
more in treated group (Fig. 3f). The mRNA 
expression of caspase-3 was upregulated in the TPE-
treated group, but downregulated in the NMU control 
(Fig. 4B). 
 
 
Fig. 3 — Representative images of the immunohistochemical
staining of samples from the NMU control and the TPE-treated
groups. a) Invasive cribriform carcinoma: More than 85% cells
exhibiting strong PCNA-positive brown nuclear immunostaining.
IP-DAB-MH ×200. b) Invasive solid cribriform carcinoma:
Cancerous cells showing moderate nuclear reaction to PCNA.
IP-DAB-MH ×200. c) Invasive tubular adenocarcinoma: Strong
diffuse cytoplasmic expression of VEGF. IP-DAB-MH ×200. d)
In situ solid cribriform carcinoma: Neoplastic cells showing mild
cytoplasmic expression of VEGF (arrow). IP-DAB-MH ×200. e)
Invasive solid tubular carcinoma: Few neoplastic cells showing
cytoplasmic reaction to caspase-3 (arrow). IP-DAB-MH ×400. f)
In situ solid cribriform carcinoma: More than 85% cancerous cells
showing strong cytoplasmic expression of caspase-3. IP-DAB-
MH ×200. g) Papillary carcinoma: Neoplastic cells showing
strong nuclear reaction to ER-α. IP-DAB-MH ×200. h) Papillary
adenoma: Distinct ER-α-positive nuclear immunostaining of
tumor cells. IP-DAB-MH ×200. i) Invasive tubular
adenocarcinoma: Strong positive MMP-9 immuno-expression in
stroma of the tumor. IP-DAB-MH ×200. j) Tubular adenoma:
mild MMP-9 expression in the cytoplasm of tumor cells
infiltrating the connective tissue. IP-DAB-MH ×200. 
 
 
Fig. 4 — Immunohistochemical (A) and mRNA (B) expression index
for different markers in the NMU control and TPE-treated groups. 
Means with an asterisk (*) indicate statistically significant differences
(p<0.05). 
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TPE Modulates expression of ER-α and ER-β 
The expression of ER-α and ER-β was assessed by 
IHC staining to evaluate the involvement of ER-α and 
ER-β signaling in NMU-induced mammary tumors 
(Fig. 3g & Fig. 4A) and the possible changes after 
TPE treatment. A significant decrease (p<0.05) in ER-
α (Fig. 3h) and ER-β expression was observed in the 
TPE-treated group in comparison with the NMU 
control (Fig. 3g). The immunohistochemical profile 
clearly indicated an elevation in the expression of ER-
α- and ER-β-positive cells in the NMU-induced 
mammary tumors (Fig. 4A). The mRNA expression 
of ER-β was decreased in the TPE-treated group, but 
was upregulated in the NMU-control group (Fig. 4B). 
 
TPE Inhibits metastasis in mammary tumors 
To assess whether TPE inhibited metastasis in 
NMU-induced mammary tumors, the expression of 
MMP-9 was assessed in tumor sections by IHC 
analysis. Tumor sections from the NMU control rats 
showed a higher cytoplasmic expression of MMP-9 
(Fig. 3i). A non-significant reduction in MMP-9 
expression in the TPE-treated group indicated that 
TPE may exert metastasis-inhibiting activity (Fig. 3j). 
 
Discussion 
Cancer is a complex and multistage disease, with 
fatal consequences, which can be induced by 
radiation, chemicals, or genetic factors3. Millions of 
new cases of mammary cancer in bitches and queens 
and breast cancer in women are diagnosed, which 
result in a high number of fatalities1. The various 
available treatment options for cancer involve huge 
expenses, many side effects, and kill normal cells in 
addition to cancer cells; therefore, phytochemicals 
may be a preferably option with respect to economics, 
reduced side effects and to increase the rate of 
survival of cancer patients7,19. Plants contain various 
bioactive principles, including phenolic compounds, 
flavonoids, alkaloids, triterpenes and tannins, which 
are responsible for the biological effects that include 
antioxidant, antitumor, antibacterial, and antiviral 
activities6,19,30. In the present study, phytochemical 
analysis revealed that TPE contained alkaloids, 
steroids, terpenoids, flavonoids, glycosides, saponins, 
carbohydrates, and phenolic compounds, which were 
concordant with the observations of previous 
studies9,31,32. 
In the present study, we hypothesized that TPE 
extract could prevent or reduce the incidence and 
progression of mammary tumors. To prove this 
hypothesis, an NMU model in Wistar rats was used. 
NMU, an alkylating carcinogen, is known to induce 
mammary tumors through a G-35 point mutation in the 
c-Ki-ras proto-oncogene in the 12th codon33. 
Furthermore, in rodent models, the mammary gland is 
a source of hormone-dependent neoplasms, which are, 
in many ways, similar to many common malignant 
tumors diagnosed in women and dogs 16,17. To explore 
the mechanism by which TPE exerted its therapeutic 
effect in NMU-induced mammary tumors, the rats 
were administered 200 mg/kg bw TPE for 2 months 
after the induction of tumors. During the experiment, 
no side effects of NMU (other than cancer) and TPE 
were observed in the rats. In the treatment group, the 
number and size of various malignant tumor types were 
reduced in comparison with the NMU control. This 
might result from the reduced proliferation of cancer 
cells, decrease in angiogenesis and extensive apoptosis 
found in tumor tissues of the TPE-treated group, as 
evidenced by a corresponding decrease in PCNA, 
VEGF, ER-α, and ER-β, and an increase in caspase-3 
biomarkers, as shown by IHC and qRT-PCR. These 
findings were also supported by a significant decrease 
in the mitotic index in the TPE-treated group in the 
H&E-stained sections. 
As the PCNA expression level varies with the cell 
cycle stage of the mammalian cell34. In the present 
study, a substantial elevation of the expression of 
PCNA was seen in the NMU control, which is a 
known carcinogen18. Conversely, a significant 
reduction was seen in treatment group, which 
suggested an anti-proliferative mechanism of TPE. 
The same observations were also reported in the use 
of a DMBA-induced rat model to evaluate the 
chemopreventive effect of TPE14. Further, the mRNA 
expression of PCNA was down regulated in the TPE 
group in comparison with the NMU control, which 
supported the antiproliferative effect of TPE. 
Angiogenesis is essential both for normal and 
abnormal tissue growth. Cancer arises owing to an 
imbalance between positive and negative angiogenic 
factors. VEGF, a multifunctional cytokine, is 
mitogenic to vascular endothelial cells and known to 
play a crucial role in angiogenesis during tumor 
growth35. Nowadays, the inhibition of angiogenesis is 
a novel strategy in antitumor therapy and its clinical 
potential has attracted significant attention36. Our 
results showed that TPE treatment resulted in a 
decrease in vascularization observed by gross 
examination, histopathology analysis and VEGF 
expression in comparison with the NMU control, 
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which was an indication of its anti-angiogenic role. 
This observation was further supported by an increase 
in intra-tumoral necrosis and decrease in the size and 
number of tumors because of inadequate blood supply 
to tumor cells. Our findings supported the possibility 
of anti-angiogenic properties as the basic mechanism 
of cancer therapeutic effects of naturally occurring 
dietary compounds37. 
Apoptosis is characterized by morphological 
changes, chromatin condensation, DNA fragmentation 
and formation of apoptotic bodies. Defects in apoptosis 
regulatory mechanisms can result in malignant 
transformation and tumor progression38. In the present 
study, a substantial increase in the induction of 
apoptosis by TPE was observed in comparison with the 
NMU control. TPE significantly increased both the 
protein and mRNA expression of the executioner 
caspase, caspase-3, which might be the reason for the 
reduction in the size and number of tumors that 
occurred in our study. These results clearly showed the 
apoptosis-inducing property of TPE. More apoptotic 
cell death may remove neoplastic clone cells and 
suppress the neoplastic process39. The results 
corroborate an earlier report of Bishayee and Mandal14, 
who reported a significant increase in DNA 
fragmentation and the proapoptotic protein Bax and 
less expression of anti-apoptotic protein Bcl-2 in 
mammary tumors triggered by DMBA; thus, this 
indicated the apoptosis-inducing activity of TPE in 
mammary tumours. A substantially decreased 
expression of caspase-3 in NMU control rats indicated 
the dysregulation of apoptosis in NMU-induced 
mammary tumors. 
Estrogen is a potent mitogen and required for 
development of normal mammary gland. Estrogen also 
plays a role in the induction and progression of 
mammary carcinoma by mediating through estrogen 
receptors, ER-α and ER-β40. ER-α is the major ER 
subtype present in the mammary epithelium. For this 
reason, targeting the estrogen receptors or blocking 
their action by using anti-estrogen compounds from 
dietary sources has recently emerged as an increasingly 
important treatment for breast cancer. In the present 
study, a substantially elevated expression of ER-α and 
ER-β in the mammary tumors of NMU control rats 
indicated an accelerated proliferation of tumor cells 
that resulted from the increased expression of estrogen 
receptors. Our findings were consistent with the 
finding of a previous study41. Interestingly, we found 
that both protein expression and mRNA expression of 
ER-α and ER-β significantly reduced in TPE-treated 
group, which suggested that ERs were a novel target of 
TPE in mammary cancer. These results are supported 
by a recent evidence, showing that the inhibition of 
estrogen receptors is an essential component of the 
mechanism of cancer preventive effects of naturally 
occurring dietary compounds42. 
Matrix metalloproteinases (MMPs) are involved in 
the breakage of extracellular matrix that play a crucial 
role in several stages of tumor progression, including 
invasion, angiogenesis and metastasis. Tumor cells 
produce increased levels of MMP enzymes that destroy 
the basement membranes and allow metastasis43. In the 
present study elevated levels of MMP-9 were observed 
in the NMU control, whereas reduced levels were 
observed in the TPE treatment group, which indicated 
the metastatic preventive potential of the extract. 
Elevated levels of MMP-9 in the NMU control 
correlated with increased number of tumors, greater 
malignancy and non-mammary tumors in the kidneys, 
lungs and ovaries (data not shown). Similar 
observations were made in breast cancer brain 
metastasis in rats by Mendes et al.44. The reduced level 
of MMP-9 in the TPE treatment group was consistent 
with other dietary compounds, such as curcumin, 
which prevent metastasis through the down regulation 
of MMP-2 and MMP-9 and the up regulation of 
expression of TIMP1 and TIMP4 in breast cancer 
cells45,46. 
 
Conclusion 
In conclusion, the results of our present study showed 
the therapeutic effect of a hydroalcoholic extract of TPE 
on NMU-induced mammary tumors in rats. TPE 
treatment slowed down the tumor growth rate, reduced 
the tumor frequency and size and showed more 
intratumoral necrosis and less malignancy in comparison 
with the NMU control. Our results showed that the 
therapeutic effect of TPE could be attributed to its 
antiproliferative, antiangiogenic, apoptosis-inducing and 
metastasis-inhibiting properties. These findings suggest 
that TPE is a promising cancer therapeutic agent, owing 
to its non-toxicity in the host. However, further 
investigations are necessary to identify the detailed 
molecular mechanisms responsible for its anticancer 
action and a comprehensive phytochemical analysis is 
required. 
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